1. Assessing Atrial Fibrillation: Real-World Data vs Clinical Trials

3. Program Goals

4. NOAC Trials Safety

5. NOAC Trials Mortality

6. From Trials to Clinical Practice

7. Real-World Data Administrative Databases

8. Registry Data

9. Medicare Database Dabigatran vs Warfarin

10. Underuse of OACs in Patients With AF

11. Why Were OACs Not Prescribed?

12. ORBIT-AF Lack of Patient Engagement

13. Warfarin TTR Is Not Ideal

14. ORBIT-AF TTR Is Not Ideal

15. ORBIT-AF Stable INR Is Not a Predictor of Future Control

16. NOAC Dosing

17. NOAC Underdosing

18. ORBIT-AF NOAC Dosing Outcomes

19. Adherence to NOAC Therapy

20. Temporary Interruptions in OAC

21. ORBIT-AF Temporary Interruptions in OAC

22. Bridging

23. Summary

24. Abbreviations